Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

End-stage renal disease in 2010

Innovative approaches to improve outcomes in transplantation

Nature Reviews Nephrology volume 7, pages 68–70 (2011)Cite this article

Renal transplantation offers the potential for improved quality and length of life to patients with end-stage renal disease; however, graft rejection and immunosuppression-related toxicities can hamper the effectiveness of this therapy. Seminal publications from 2010 have addressed these obstacles, and provide insight into new and innovative approaches to improve outcomes in renal transplant recipients.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

References

  1. Vincenti, F. et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am. J. Transplant. 10, 536–546 (2010).

    Article  Google Scholar 

  2. Durrbach, A. et al. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENIFIT-EXT study). Am. J. Transplant. 10, 547–557 (2010).

    Article  CAS  Google Scholar 

  3. Walsh, R. C. et al. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection. Transplantation 89, 277–284 (2010).

    Article  CAS  Google Scholar 

  4. Sberro-Soussan, R. et al. Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am. J. Transplant. 10, 681–686 (2010).

    Article  CAS  Google Scholar 

  5. Salgo, R. et al. Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)maglignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded controlled clinical trial. Am. J. Transplant. 10, 1385–1395 (2010).

    Article  CAS  Google Scholar 

  6. Poommipanit, N. et al. Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: an analysis of the organ procurement transplant network/united network of organ sharing database. Transplantation 89, 277–284 (2010).

    Article  Google Scholar 

  7. Stegall, M. D. et al. Terminal complement inhibition decreases early acute humoral rejection in sensitized renal transplant recipients [abstract 1]. Am. J.Transplant. 10, 39 (2010).

    Article  Google Scholar 

  8. Robbins, W. R., Schmidt, W. K. & Lee, V. J. LIM-0705, an activator of specific ABC transporters, prevents and treats tacrolimus-induced hyperglycemia in the rat [abstract 148]. Am. J. Transplant. 10, 84 (2010).

    Google Scholar 

  9. Robbins, W. R. et al. LIM-0705 activates specific ABC transporters allowing efflux of tacrolimus out of rat kidney and pancreas that may help ameliorate toxicity [abstract 149]. Am. J. Transplant. 10, 84 (2010).

    Google Scholar 

  10. Robbins, W. R. et al. LIM-0705 an activator of specific ABC transporters, prevents and treats tacrolimus-induced renal tubular vacuolization in a rat model [abstract 150]. Am. J. Transplant. 10, 85 (2010).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thomas E. Starzl Transplantation Institute, UPMC Montefiore 7S, 3459 5th Avenue, Pittsburgh, 15213, PA, USA

    Ron Shapiro

Authors
  1. Ron Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author is on a Data Monitoring Committee for Bristol–Myers Squibb and StemCells Inc., and is a member of Genentech's Valcyte Regional Advisory Board.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shapiro, R. Innovative approaches to improve outcomes in transplantation. Nat Rev Nephrol 7, 68–70 (2011). https://doi.org/10.1038/nrneph.2010.179

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.179

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing